AstraZeneca Profits Soar On Cancer Drugs, Alexion Buy
London, Feb 9 (UrduPoint / Pakistan Point News - 9th Feb, 2023 ) :Anglo-Swedish drugmaker AstraZeneca on Thursday posted surging annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover.
Profit after tax rocketed to $3.3 billion (3.
1 billion Euros) last year from just $112 million in 2021 on costs linked to the Alexion purchase, AstraZeneca said in a results statement.
AstraZeneca, which completed the takeover at a cost of $39 billion in 2021, saw revenues soar almost one fifth to $44.4 billion last year.
This was thanks to a strong contribution from cancer treatments that offset sliding fourth-quarter sales of its Covid vaccine.
AstraZeneca forecast Covid-19 medicine sales to decline "significantly" in 2023, with "minimal revenue" from its jab Vaxzevria.
Recent Stories
Dubai Chamber of Digital Economy discusses future of AI and software development
Dubai Supreme Council of Energy reviews DEWA’s achievements in AI and data man ..
GKSD Investment Holding announces investment of 125 million euros in university ..
Annual Investment Meeting tackles global market challenges, future investment op ..
President of Global Council for Tolerance and Peace meets leaders of religious o ..
Second UAE aid ship arrives at Latakia Port
Education - Urdu News - Car Prices - Breaking News - English News - Live Tv Channels - Urdu Horoscope - Horoscope in Urdu - Muslim Names in Urdu - Urdu Poetry - Love Poetry - Sad Poetry - Prize Bond - Mobile Prices in Pakistan - PTV Sports - English to Urdu - Big Ticket - Translate English to Urdu - Ramadan Calendar - Prayer Times - DDF Raffle - Islamic Calendar - Events - Today Islamic Date - Travel - UAE Raffles - Travel Guide - Arabic - Urdu Cooking Recipes - Directory - Pakistan Results - Past Papers - BISE - Schools in Pakistan - Academies & Tuition Centers